{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:00:41Z","timestamp":1792411241466,"version":"4.4.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lymphatic Research and Biology"],"published-print":{"date-parts":[[2019,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lymphedema is a disease of the skin and subcutaneous tissue resulting from a disturbance in lymph flow. Anyone can be affected, and causes include cancer therapy when lymph nodes are removed or irradiated, the parasitic disease lymphatic filariasis, and damage caused by exposure to irritant soils known as podoconiosis. Manifest lymphedema is progressive and a major contributor to disability, stigma, and social isolation for affected people. Although the pathogenesis of connective tissue changes in lymphedema will follow a similar course regardless of the disease of causation, several systems are used to stage progression. Disparity in these staging systems leads to inconsistency in reporting of the severity of lymphedema and prevents meta-analysis of research results. In the global health environment, integrated morbidity management for chronic illness is essential to meet the needs of affected people and to be sustainable for health care systems. Clinical descriptors for staging criteria within each system may assist clinicians in assessment and provide a format for consistency in reporting by lymphedema researchers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Results:<\/jats:title>\n                    <jats:p>Lymphedema staging systems used in oncology, filariasis, and podoconiosis settings were reviewed and the assessment techniques, diagnostic procedures, and clinical observations used by each system are described. The most commonly used staging systems are compared to identify similarities, and a matrix approach to lymphedema staging is proposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A universal staging system would contribute to more consistent reporting of research on and clinical management of lymphedema arising from multiple causes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/lrb.2018.0063","type":"journal-article","created":{"date-parts":[[2019,2,21]],"date-time":"2019-02-21T11:12:29Z","timestamp":1550747549000},"page":"550-556","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":40,"title":["Comparison of Staging Systems to Assess Lymphedema Caused by Cancer Therapies, Lymphatic Filariasis, and Podoconiosis"],"prefix":"10.1177","volume":"17","author":[{"given":"Janet","family":"Douglass","sequence":"first","affiliation":[{"name":"Department of Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Kelly-Hope","sequence":"additional","affiliation":[{"name":"Department of Tropical Disease Biology, Centre for Neglected Tropical Diseases, Liverpool School of Tropical Medicine, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"e_1_3_3_2_2","first-page":"242","article-title":"Lymphedema: Separating fact from fiction","volume":"26","author":"McLaughlin SA","year":"2012","unstructured":"McLaughlin SA. Lymphedema: Separating fact from fiction. Oncology (Williston Park), 2012; 26:242\u2013249.","journal-title":"Oncology (Williston Park)"},{"key":"e_1_3_3_3_2","first-page":"6","article-title":"Diagnostic application of lymphoscintigraphy in the management of lymphoedema","volume":"13","author":"Sadeghi R","year":"2010","unstructured":"Sadeghi R, , Kazemzadeh G, , Keshtgar M. Diagnostic application of lymphoscintigraphy in the management of lymphoedema. Hell J Nucl Med, 2010; 13:6\u201310.","journal-title":"Hell J Nucl Med"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1610-0387.2009.07099.x","article-title":"Podoconiosis\u2014Non-filarial geochemical elephantiasis\u2014A neglected tropical disease? [in English, German]","volume":"8","author":"Nenoff P","year":"2010","unstructured":"Nenoff P, et al. Podoconiosis\u2014Non-filarial geochemical elephantiasis\u2014A neglected tropical disease? [in English, German]. J Dtsch Dermatol Ges, 2010; 8:7\u201314.","journal-title":"J Dtsch Dermatol Ges"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.12224"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2011.03.008"},{"key":"e_1_3_3_7_2","first-page":"170","article-title":"The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology","volume":"49","author":"ISL","year":"2016","unstructured":"ISL. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology, 2016; 49:170\u2013184.","journal-title":"Lymphology"},{"key":"e_1_3_3_8_2","volume-title":"Lymphatic Pathology and Immunopathology in Filariasis. Report of the Twelfth Meeting in Filariasis. TDR\/FIL-SWG12, 85.3","author":"WHO","year":"1985","unstructured":"WHO. Lymphatic Pathology and Immunopathology in Filariasis. Report of the Twelfth Meeting in Filariasis. TDR\/FIL-SWG12, 85.3. Geneva: World Health Organization; 1985."},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2007.08.013"},{"key":"e_1_3_3_10_2","first-page":"16","article-title":"Upper extremity lymphedema after treatment for breast cancer: A review of the literature","volume":"53","author":"Meneses KD","year":"2007","unstructured":"Meneses KD, , McNees MP. Upper extremity lymphedema after treatment for breast cancer: A review of the literature. Ostomy Wound Manage, 2007; 53:16\u201329.","journal-title":"Ostomy Wound Manage"},{"key":"e_1_3_3_11_2","first-page":"541","article-title":"Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013","volume":"32","author":"Lee BB","year":"2013","unstructured":"Lee BB, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol, 2013; 32:541\u2013574.","journal-title":"Int Angiol"},{"key":"e_1_3_3_12_2","first-page":"24","article-title":"Chronic inflammatory reaction in lymphedema","volume":"28","author":"Hussain SA","year":"2000","unstructured":"Hussain SA. Chronic inflammatory reaction in lymphedema. Phlebolymphology, 2000; 28:24\u201329.","journal-title":"Phlebolymphology"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71608"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3517"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13561-018-0194-6"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003319"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v5.i3.241"},{"key":"e_1_3_3_18_2","first-page":"27","article-title":"A systematic review of care delivery models and economic analyses in lymphedema: Health policy impact (2004\u20132011)","volume":"46","author":"Stout NL","year":"2013","unstructured":"Stout NL, et al. A systematic review of care delivery models and economic analyses in lymphedema: Health policy impact (2004\u20132011). Lymphology, 2013; 46:27\u201341.","journal-title":"Lymphology"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/17441692.2010.549140"},{"key":"e_1_3_3_20_2","first-page":"180","article-title":"A search for consensus on the staging of lymphedema","volume":"37","author":"Ryan TJ","year":"2004","unstructured":"Ryan TJ. A search for consensus on the staging of lymphedema. Lymphology, 2004; 37:180\u2013181.","journal-title":"Lymphology"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2014.0016"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2008.10.003"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004740"},{"key":"e_1_3_3_24_2","unstructured":"National Institutes of Health and National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 5.0. U.S. Department of Health and Human Services; 2017."},{"key":"e_1_3_3_25_2","first-page":"84","article-title":"The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology","volume":"36","author":"ISL","year":"2003","unstructured":"ISL. The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology. Lymphology, 2003; 36:84\u201391.","journal-title":"Lymphology"},{"key":"e_1_3_3_26_2","volume-title":"International Consensus","author":"ILF","year":"2006","unstructured":"ILF. Best practice for the management of lymphoedema. In: MacGregor L, ed. International Consensus. London: Medical Education Partnership Ltd.; 2006."},{"key":"e_1_3_3_27_2","volume-title":"Informal Consultation on Evaluation of Morbidity in Lymphatic Filariasis, Tuberculosis Research Centre, Madras, 10\u201311 February 1992. Document WHO\/TDR\/FIL\/92.3","author":"WHO","year":"1992","unstructured":"WHO. Informal Consultation on Evaluation of Morbidity in Lymphatic Filariasis, Tuberculosis Research Centre, Madras, 10\u201311 February 1992. Document WHO\/TDR\/FIL\/92.3. Geneva: World Health Organization; 1992."},{"key":"e_1_3_3_28_2","volume-title":"Basic Lymphoedema Management, Treatment and Prevention Problems Associated with Lymphatic Filariasis","author":"Dreyer G","year":"2002","unstructured":"Dreyer G, et al. Basic Lymphoedema Management, Treatment and Prevention Problems Associated with Lymphatic Filariasis. USA: Hollis Publishing Company; 2002."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2006.74.500"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005748"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002100"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2008.02133.x"},{"key":"e_1_3_3_33_2","first-page":"40","article-title":"Skin changes in filarial and non-filarial lymphoedema of the lower extremities","volume":"44","author":"Olszewski WL","year":"1993","unstructured":"Olszewski WL, et al. Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol, 1993; 44:40\u201344.","journal-title":"Trop Med Parasitol"},{"key":"e_1_3_3_34_2","first-page":"106","article-title":"Systematic review of breast cancer related lymphoedema: Making a balanced decision to perform an axillary clearance","volume":"5","author":"G\u00f6ker M","year":"2013","unstructured":"G\u00f6ker M, et al. Systematic review of breast cancer related lymphoedema: Making a balanced decision to perform an axillary clearance. Facts Views Vis Obgyn, 2013; 5:106\u2013115.","journal-title":"Facts Views Vis Obgyn"},{"key":"e_1_3_3_35_2","article-title":"Early detection and treatment of subclinical lymphedema in patients with breast cancer","author":"Asl\u0131 GC","year":"2018","unstructured":"Asl\u0131 GC, , Emel E, , Ayt\u00fcl \u00c7F. Early detection and treatment of subclinical lymphedema in patients with breast cancer. Lymphat Res Biol, 2018. [Epub ahead of print]; DOI: 10.1089\/lrb.2018.0033.","journal-title":"Lymphat Res Biol"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2014.0035"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2017.0069"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2012.0015"}],"container-title":["Lymphatic Research and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/lrb.2018.0063","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lrb.2018.0063","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/lrb.2018.0063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:12:08Z","timestamp":1777666328000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/lrb.2018.0063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10,1]]}},"alternative-id":["10.1089\/lrb.2018.0063"],"URL":"https:\/\/doi.org\/10.1089\/lrb.2018.0063","relation":{},"ISSN":["1539-6851","1557-8585"],"issn-type":[{"value":"1539-6851","type":"print"},{"value":"1557-8585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]}}}